Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Assets (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Assets data on record, last reported at $215.4 million in Q3 2021.

  • For Q3 2021, Assets rose 53.99% year-over-year to $215.4 million; the TTM value through Sep 2021 reached $215.4 million, up 53.99%, while the annual FY2020 figure was $250.9 million, 407.69% up from the prior year.
  • Assets reached $215.4 million in Q3 2021 per COGT's latest filing, down from $228.5 million in the prior quarter.
  • Across five years, Assets topped out at $250.9 million in Q4 2020 and bottomed at $31.1 million in Q2 2020.
  • Average Assets over 4 years is $115.1 million, with a median of $85.9 million recorded in 2018.
  • Peak YoY movement for Assets: crashed 55.19% in 2020, then surged 635.84% in 2021.
  • A 4-year view of Assets shows it stood at $85.9 million in 2018, then crashed by 42.48% to $49.4 million in 2019, then soared by 407.69% to $250.9 million in 2020, then fell by 14.16% to $215.4 million in 2021.
  • Per Business Quant database, its latest 3 readings for Assets were $215.4 million in Q3 2021, $228.5 million in Q2 2021, and $237.6 million in Q1 2021.